Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
Add more filters










Publication year range
1.
Brain Res ; 1754: 147254, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33422542

ABSTRACT

Schizophrenia is a neurodevelopmental psychiatric disorder, encompassing genetic and environmental risk factors. For several decades, investigators have been implementing the use of lesions of the neonatal rodent hippocampus to model schizophrenia, resulting in a broad spectrum of adult schizophrenia-related behavioral changes. Despite the extensive use of these proposed animal models of schizophrenia, the mechanisms by which these lesions result in schizophrenia-like behavioral alterations remain unclear. Here we provide in vivo evidence that transient pharmacological inactivation of the hippocampus via tetrodotoxin microinjections or a genetic reduction in brain derived neurotrophic factor (BDNF) protein levels (BDNF+/- rats) lead to global DNA hypomethylation, disrupted maturation of the neuronal nucleus and aberrant acoustic startle response in the adult rat. The similarity between the effects of the two treatments strongly indicate that BDNF signaling is involved in effects obtained after the TTX microinjections. These findings may shed light on the cellular mechanisms underlying the phenotypical features of neonatal transient inhibition of the hippocampus as a preclinical model of schizophrenia and suggest that BDNF signaling represents a target pathway for development of novel treatment therapies.


Subject(s)
Behavior, Animal/physiology , Brain-Derived Neurotrophic Factor/deficiency , DNA Methylation/physiology , DNA/metabolism , Hippocampus/metabolism , Animals , Animals, Newborn , Brain-Derived Neurotrophic Factor/metabolism , Neurons/metabolism , Rats , Reflex, Startle/genetics , Reflex, Startle/physiology , Schizophrenia/genetics , Schizophrenia/metabolism
2.
Nat Commun ; 11(1): 462, 2020 01 23.
Article in English | MEDLINE | ID: mdl-31974374

ABSTRACT

Human induced pluripotent stem cells (hiPSCs) are a powerful model of neural differentiation and maturation. We present a hiPSC transcriptomics resource on corticogenesis from 5 iPSC donor and 13 subclonal lines across 9 time points over 5 broad conditions: self-renewal, early neuronal differentiation, neural precursor cells (NPCs), assembled rosettes, and differentiated neuronal cells. We identify widespread changes in the expression of both individual features and global patterns of transcription. We next demonstrate that co-culturing human NPCs with rodent astrocytes results in mutually synergistic maturation, and that cell type-specific expression data can be extracted using only sequencing read alignments without cell sorting. We lastly adapt a previously generated RNA deconvolution approach to single-cell expression data to estimate the relative neuronal maturity of iPSC-derived neuronal cultures and human brain tissue. Using many public datasets, we demonstrate neuronal cultures are maturationally heterogeneous but contain subsets of neurons more mature than previously observed.


Subject(s)
Cell Differentiation/genetics , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/physiology , Neural Stem Cells/physiology , Transcriptome , Algorithms , Animals , Astrocytes/cytology , Cells, Cultured , Cerebral Cortex/cytology , Coculture Techniques , Databases, Genetic , Gene Expression Regulation , Humans , Models, Neurological , Neural Stem Cells/cytology , Neurons/cytology , Neurons/physiology , Rats
3.
Article in English | MEDLINE | ID: mdl-30568848

ABSTRACT

The cerebellum, a derivative of the hindbrain, plays a crucial role in balance and posture as well as in higher cognitive and locomotive processes. Cerebellar development is initiated during the segmental phase of hindbrain formation. Here, we describe the phenotype, of a single surviving adult conditional mouse mutant mouse, in which Sox2 function is ablated in embryonic radial glial cells by means of hGFAP-CRE. The single Sox2RGINV/mosaic adult mutant mouse displays motor disability, microsomia, reduced Central Nervous System (CNS) size and cerebellar defects associated with human genetically related congenital abnormalities.

4.
Bioorg Med Chem Lett ; 28(19): 3231-3235, 2018 10 15.
Article in English | MEDLINE | ID: mdl-30170942

ABSTRACT

Due to increased interest in As(III) S-adenosylmethionine methyltransferase (AS3MT), a search for chemical probes that can help elucidate function was initiated. A homology model was built based on related enzymes, and virtual screening produced 426 potential hits. Evaluation of these compounds in a functional enzymatic assay revealed several modest inhibitors including an O-substituted 2-amino-3-cyano indole scaffold. Two iterations of near neighbor searches revealed compound 5 as a potent inhibitor of AS3MT with good selectivity over representative methyltransferases DOT1L and NSD2 as well as a representative set of diverse receptors. Compound 5 should prove to be a useful tool to investigate the role of AS3MT and a potential starting point for further optimization.


Subject(s)
Enzyme Inhibitors/pharmacology , Methyltransferases/antagonists & inhibitors , Humans
5.
Trends Mol Med ; 24(9): 805-820, 2018 09.
Article in English | MEDLINE | ID: mdl-30006147

ABSTRACT

Use of human pluripotent stem cells (hPSCs) and their differentiated derivatives have led to recent proof-of-principle drug discoveries, defining a pathway to the implementation of hPSC-based drug discovery (hPDD). Current hPDD strategies, however, have inevitable conceptual biases and technological limitations, including the dimensionality of cell-culture methods, cell maturity and functionality, experimental variability, and data reproducibility. In this review, we dissect representative hPDD systems via analysis of hPSC-based 2D-monolayers, 3D culture, and organoids. We discuss mechanisms of drug discovery and drug repurposing, and roles of membrane drug transporters in tissue maturation and hPDD using the example of drugs that target various mutations of CFTR, the cystic fibrosis transmembrane conductance regulator gene, in patients with cystic fibrosis.


Subject(s)
Cell Culture Techniques/methods , Drug Development/methods , Drug Discovery/methods , Pluripotent Stem Cells/drug effects , ATP-Binding Cassette Transporters/metabolism , Animals , Cell Culture Techniques/instrumentation , Cystic Fibrosis/drug therapy , Cystic Fibrosis/genetics , Cystic Fibrosis/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Drug Development/instrumentation , Drug Discovery/instrumentation , Humans , Molecular Targeted Therapy/methods , Organoids/cytology , Organoids/drug effects , Organoids/metabolism , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism
6.
Stem Cells ; 36(1): 11-21, 2018 01.
Article in English | MEDLINE | ID: mdl-28948674

ABSTRACT

Lineage commitment and differentiation of skeletal stem cells/bone marrow stromal cells (SSCs/BMSCs, often called bone marrow-derived "mesenchymal stem/stromal" cells) offer an important opportunity to study skeletal and hematopoietic diseases, and for tissue engineering and regenerative medicine. Currently, many studies in this field have relied on cell lineage tracing methods in mouse models, which have provided a significant advancement in our knowledge of skeletal and hematopoietic stem-cell niches in bone marrow (BM). However, there is a lack of agreement in numerous fundamental areas, including origins of various BM stem-cell niches, cell identities, and their physiological roles in the BM. In order to resolve these issues, we propose a new hypothesis of "paralogous" stem-cell niches (PSNs); that is, progressively altered parallel niches within an individual species throughout the life span of the organism. A putative PSN code seems to be plausible based on analysis of transcriptional signatures in two representative genes that encode Nes-GFP and leptin receptors, which are frequently used to monitor SSC lineage development in BM. Furthermore, we suggest a dynamic paralogous BM niche (PBMN) model that elucidates the coupling and uncoupling mechanisms between BM stem-cell niches and their zones of active regeneration during different developmental stages. Elucidation of these PBMNs would enable us to resolve the existing controversies, thus paving the way to achieving precision regenerative medicine and pharmaceutical applications based on these BM cell resources. Stem Cells 2018;36:11-21.


Subject(s)
Bone Marrow/metabolism , Hematopoietic Stem Cells/metabolism , Stem Cell Niche/genetics , Stem Cells/metabolism , Cell Differentiation , Cell Lineage , Humans
7.
Front Physiol ; 7: 127, 2016.
Article in English | MEDLINE | ID: mdl-27148066

ABSTRACT

Temporal and spatial control of gene expression can be achieved using an inducible system as a fundamental tool for regulated transcription in basic, applied and eventually in clinical research. We describe a novel "hit and run" inducible direct reprogramming approach. In a single step, 2 days post-transfection, transiently transfected Sox2(FLAG) under the Leu3p-αIPM inducible control (iSox2) triggers the activation of endogenous Sox2, redirecting primary astrocytes into abundant distinct nestin-positive radial glia cells. This technique introduces a unique novel tool for safe, rapid and efficient reprogramming amendable to regenerative medicine.

8.
Stem Cells Transl Med ; 3(7): 867-78, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24855277

ABSTRACT

The ability to differentiate induced pluripotent stem cells (iPSCs) into committed skeletal progenitors could allow for an unlimited autologous supply of such cells for therapeutic uses; therefore, we attempted to create novel bone-forming cells from human iPSCs using lines from two distinct tissue sources and methods of differentiation that we previously devised for osteogenic differentiation of human embryonic stem cells, and as suggested by other publications. The resulting cells were assayed using in vitro methods, and the results were compared with those obtained from in vivo transplantation assays. Our results show that true bone was formed in vivo by derivatives of several iPSC lines, but that the successful cell lines and differentiation methodologies were not predicted by the results of the in vitro assays. In addition, bone was formed equally well from iPSCs originating from skin or bone marrow stromal cells (also known as bone marrow-derived mesenchymal stem cells), suggesting that the iPSCs did not retain a "memory" of their previous life. Furthermore, one of the iPSC-derived cell lines formed verifiable cartilage in vivo, which likewise was not predicted by in vitro assays.


Subject(s)
Biological Assay/methods , Cell Differentiation , Chondrocytes/metabolism , Chondrogenesis , Induced Pluripotent Stem Cells/metabolism , Mesenchymal Stem Cells/metabolism , Osteoblasts/metabolism , Osteogenesis , Aged , Aged, 80 and over , Animals , Cell Line , Cellular Reprogramming , Chondrocytes/transplantation , Female , Gene Expression Regulation, Developmental , Humans , Induced Pluripotent Stem Cells/transplantation , Male , Mesenchymal Stem Cell Transplantation , Mice , Osteoblasts/transplantation , Phenotype , Transfection
9.
Stem Cell Res ; 12(3): 610-21, 2014 May.
Article in English | MEDLINE | ID: mdl-24603366

ABSTRACT

Human pluripotent stem cells (hPSCs) have two potentially attractive applications: cell replacement-based therapies and drug discovery. Both require the efficient generation of large quantities of clinical-grade stem cells that are free from harmful genomic alterations. The currently employed colony-type culture methods often result in low cell yields, unavoidably heterogeneous cell populations, and substantial chromosomal abnormalities. Here, we shed light on the structural relationship between hPSC colonies/embryoid bodies and early-stage embryos in order to optimize current culture methods based on the insights from developmental biology. We further highlight core signaling pathways that underlie multiple epithelial-to-mesenchymal transitions (EMTs), cellular heterogeneity, and chromosomal instability in hPSCs. We also analyze emerging methods such as non-colony type monolayer (NCM) and suspension culture, which provide alternative growth models for hPSC expansion and differentiation. Furthermore, based on the influence of cell-cell interactions and signaling pathways, we propose concepts, strategies, and solutions for production of clinical-grade hPSCs, stem cell precursors, and miniorganoids, which are pivotal steps needed for future clinical applications.


Subject(s)
Cell Differentiation , Cell Proliferation , Mammals/embryology , Pluripotent Stem Cells/cytology , Signal Transduction , Animals , Humans , Mammals/genetics , Mammals/metabolism , Pluripotent Stem Cells/metabolism
10.
Cell Stem Cell ; 14(1): 13-26, 2014 Jan 02.
Article in English | MEDLINE | ID: mdl-24388173

ABSTRACT

Human pluripotent stem cells (hPSCs) provide powerful resources for application in regenerative medicine and pharmaceutical development. In the past decade, various methods have been developed for large-scale hPSC culture that rely on combined use of multiple growth components, including media containing various growth factors, extracellular matrices, 3D environmental cues, and modes of multicellular association. In this Protocol Review, we dissect these growth components by comparing cell culture methods and identifying the benefits and pitfalls associated with each one. We further provide criteria, considerations, and suggestions to achieve optimal cell growth for hPSC expansion, differentiation, and use in future therapeutic applications.


Subject(s)
Cell Culture Techniques/methods , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/transplantation , Cell Differentiation , Humans
11.
Stem Cells ; 32(3): 770-8, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24155149

ABSTRACT

The ex vivo expansion of stem cells is making major contribution to biomedical research. The multipotent nature of neural precursors acutely isolated from the developing central nervous system has been established in a series of studies. Understanding the mechanisms regulating cell expansion in tissue culture would support their expanded use either in cell therapies or to define disease mechanisms. Basic fibroblast growth factor (FGF2) and insulin, ligands for tyrosine kinase receptors, are sufficient to sustain neural stem cells (NSCs) in culture. Interestingly, real-time imaging shows that these cells become multipotent every time they are passaged. Here, we analyze the role of FGF2 and insulin in the brief period when multipotent cells are present. FGF2 signaling results in the phosphorylation of Erk1/2, and activation of c-Fos and c-Jun that lead to elevated cyclin D mRNA levels. Insulin signals through the PI3k/Akt pathway to regulate cyclins at the post-transcriptional level. This precise Boolean regulation extends our understanding of the proliferation of multipotent NSCs and provides a basis for further analysis of proliferation control in the cell states defined by real-time mapping of the cell lineages that form the central nervous system.


Subject(s)
Cyclin D/genetics , Fibroblast Growth Factor 2/pharmacology , Insulin/pharmacology , Multipotent Stem Cells/cytology , Neural Stem Cells/metabolism , Signal Transduction/drug effects , Animals , Cell Proliferation/drug effects , Cyclin D/metabolism , DNA/biosynthesis , Female , Intracellular Space/drug effects , Intracellular Space/enzymology , Mice , Mice, Inbred C57BL , Models, Biological , Neural Stem Cells/cytology , Neural Stem Cells/drug effects , Protein Biosynthesis/drug effects , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/metabolism , Transcription, Genetic/drug effects
12.
Stem Cell Res ; 10(1): 57-66, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23117585

ABSTRACT

Much of the excitement generated by induced pluripotent stem cell technology is concerned with the possibility of disease modeling as well as the potential for personalized cell therapy. However, to pursue this it is important to understand the 'normal' pluripotent state including its inherent variability. We have performed various molecular profiling assays for 21 hESC lines and 8 hiPSC lines to generate a comprehensive snapshot of the undifferentiated state of pluripotent stem cells. Analysis of the gene expression data revealed no iPSC-specific gene expression pattern in accordance with previous reports. We further compared cells, differentiated as embryoid bodies in 2 media proposed to initiate differentiation towards separate cell fates, as well as 20 adult tissues. From this analysis we have generated a gene list which defines pluripotency and establishes a baseline for the pluripotent state. Finally, we provide lists of genes enriched under both differentiation conditions which show the proposed bias toward independent cell fates.


Subject(s)
Databases, Factual , Pluripotent Stem Cells/metabolism , Animals , Cell Line , Gene Expression Profiling , Humans , Mice , National Institutes of Health (U.S.) , Pluripotent Stem Cells/cytology , Principal Component Analysis , United States
13.
Stem Cells ; 30(10): 2175-87, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22887864

ABSTRACT

The expression and function of several multidrug transporters (including ABCB1 and ABCG2) have been studied in human cancer cells and in mouse and human adult stem cells. However, the expression of ABCG2 in human embryonic stem cells (hESCs) remains unclear. Limited and contradictory results in the literature from two research groups have raised questions regarding its expression and function. In this study, we used quantitative real-time PCR, Northern blots, whole genome RNA sequencing, Western blots, and immunofluorescence microscopy to study ABCG2 expression in hESCs. We found that full-length ABCG2 mRNA transcripts are expressed in undifferentiated hESC lines. However, ABCG2 protein was undetectable even under embryoid body differentiation or cytotoxic drug induction. Moreover, surface ABCG2 protein was coexpressed with the differentiation marker stage-specific embryonic antigen-1 of hESCs, following constant BMP-4 signaling at days 4 and 6. This expression was tightly correlated with the downregulation of two microRNAs (miRNAs) (i.e., hsa-miR-519c and hsa-miR-520h). Transfection of miRNA mimics and inhibitors of these two miRNAs confirmed their direct involvement in the regulation ABCG2 translation. Our findings clarify the controversy regarding the expression of the ABCG2 gene and also provide new insights into translational control of the expression of membrane transporter mRNAs by miRNAs in hESCs.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Embryonic Stem Cells/metabolism , Gene Expression Regulation , MicroRNAs/genetics , Neoplasm Proteins/genetics , RNA, Messenger/biosynthesis , ATP Binding Cassette Transporter, Subfamily G, Member 2 , ATP-Binding Cassette Transporters/metabolism , Animals , Bone Morphogenetic Protein 4/genetics , Bone Morphogenetic Protein 4/metabolism , Cell Differentiation , Cells, Cultured , Embryonic Stem Cells/cytology , Feeder Cells , Fibroblasts , Humans , Lewis X Antigen/genetics , Lewis X Antigen/metabolism , Mice , MicroRNAs/metabolism , Neoplasm Proteins/metabolism , Protein Biosynthesis , Transfection
14.
Stem Cell Res ; 9(3): 237-48, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22910561

ABSTRACT

Regenerative medicine, relying on human embryonic stem cell (hESC) technology, opens promising new avenues for therapy of many severe diseases. However, this approach is restricted by limited production of the desired cells due to the refractory properties of hESC growth in vitro. It is further hindered by insufficient control of cellular stress, growth rates, and heterogeneous cellular states under current culture conditions. In this study, we report a novel cell culture method based on a non-colony type monolayer (NCM) growth. Human ESCs under NCM remain pluripotent as determined by teratoma assays and sustain the potential to differentiate into three germ layers. This NCM culture has been shown to homogenize cellular states, precisely control growth rates, significantly increase cell production, and enhance hESC recovery from cryopreservation without compromising chromosomal integrity. This culture system is simple, robust, scalable, and suitable for high-throughput screening and drug discovery.


Subject(s)
Cell Culture Techniques/methods , Cell Proliferation , Embryonic Stem Cells/cytology , Cell Differentiation , Cell Line , Gene Expression , Humans
15.
Gastroenterology ; 142(3): 602-11, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22138358

ABSTRACT

BACKGROUND & AIMS: Many studies of embryonic stem cells have investigated direct cell replacement of damaged tissues, but little is known about how donor cell-derived signals affect host tissue regeneration. We investigated the direct and indirect roles of human embryonic stem cell-derived cells in liver repair in mice. METHODS: To promote the initial differentiation of human embryonic stem cells into mesendoderm, we activated the ß-catenin signaling pathway with lithium; cells were then further differentiated into hepatocyte-like cells. The differentiated cells were purified by indocyanine green staining and laser microdissection and characterized by immunostaining, polymerase chain reaction, biochemical function, electron microscopy, and transplantation analyses. To investigate indirect effects of these cells, secreted proteins (secretomes) were analyzed by a label-free quantitative mass spectrometry. Carbon tetrachloride was used to induce acute liver injury in mice; cells or secreted proteins were administered by intrasplenic or intraperitoneal injection, respectively. RESULTS: The differentiated hepatocyte-like cells had multiple features of normal hepatocytes, engrafted efficiently into mice, and continued to have hepatic features; they promoted proliferation of host hepatocytes and revascularization of injured host liver tissues. Proteomic analysis identified proteins secreted from these cells that might promote host tissue repair. Injection of the secreted proteins into injured livers of mice promoted significant amounts of tissue regeneration without cell grafts. CONCLUSIONS: Hepatocyte-like cells derived from human embryonic stem cells contribute to recovery of injured liver tissues in mice, not only by cell replacement but also by delivering trophic factors that support endogenous liver regeneration.


Subject(s)
Cell Differentiation , Cell Proliferation , Chemical and Drug Induced Liver Injury/surgery , Embryonic Stem Cells/transplantation , Hepatocytes/transplantation , Induced Pluripotent Stem Cells/transplantation , Liver Regeneration , Liver/pathology , Animals , Biomarkers/metabolism , Carbon Tetrachloride , Cell Differentiation/drug effects , Cell Separation/methods , Cells, Cultured , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Coculture Techniques , Disease Models, Animal , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/metabolism , Hepatocytes/drug effects , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Immunohistochemistry , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/metabolism , Laser Capture Microdissection , Lithium Chloride/pharmacology , Liver/blood supply , Liver/metabolism , Mass Spectrometry , Mice , Mice, Inbred BALB C , Mice, Nude , Microscopy, Electron , Neovascularization, Physiologic , Polymerase Chain Reaction , Proteomics/methods , Time Factors , Wound Healing
16.
Cell Stem Cell ; 8(3): 318-25, 2011 Mar 04.
Article in English | MEDLINE | ID: mdl-21362571

ABSTRACT

Pluripotent stem cells provide a platform to interrogate control elements that function to generate all cell types of the body. Despite their utility for modeling development and disease, the relationship of mouse and human pluripotent stem cell states to one another remains largely undefined. We have shown that mouse embryonic stem (ES) cells and epiblast stem cells (EpiSCs) are distinct, pluripotent states isolated from pre- and post-implantation embryos respectively. Human ES cells are different than mouse ES cells and share defining features with EpiSCs, yet are derived from pre-implantation human embryos. Here we show that EpiSCs can be routinely derived from pre-implantation mouse embryos. The preimplantation-derived EpiSCs exhibit molecular features and functional properties consistent with bona fide EpiSCs. These results provide a simple method for isolating EpiSCs and offer direct insight into the intrinsic and extrinsic mechanisms that regulate the acquisition of distinct pluripotent states.


Subject(s)
Blastocyst/cytology , Cell Separation/methods , Germ Layers/cytology , Stem Cells/cytology , Animals , Base Sequence , Blastocyst/metabolism , Cell Differentiation/genetics , CpG Islands/genetics , DNA Methylation/genetics , Gene Expression Profiling , Gene Expression Regulation, Developmental , Humans , Mice , Molecular Sequence Data , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Stem Cells/metabolism
17.
PLoS One ; 5(5): e10841, 2010 May 26.
Article in English | MEDLINE | ID: mdl-20520777

ABSTRACT

BACKGROUND: New mechanisms that regulate neural stem cell (NSC) expansion will contribute to improved assay systems and the emerging regenerative approach that targets endogenous stem cells. Expanding knowledge on the control of stem cell self renewal will also lead to new approaches for targeting the stem cell population of cancers. METHODOLOGY/PRINCIPAL FINDINGS: Here we show that Cholera toxin regulates two recently characterized NSC markers, the Tie2 receptor and the transcription factor Hes3, and promotes the expansion of NSCs in culture. Cholera toxin increases immunoreactivity for the Tie2 receptor and rapidly induces the nuclear localization of Hes3. This is followed by powerful cultured NSC expansion and induction of proliferation both in the presence and absence of mitogen. CONCLUSIONS/SIGNIFICANCE: Our data suggest a new cell biological mechanism that regulates the self renewal and differentiation properties of stem cells, providing a new logic to manipulate NSCs in the context of regenerative disease and cancer.


Subject(s)
Brain/cytology , Cholera Toxin/pharmacology , Fetus/cytology , Neurons/cytology , Signal Transduction/drug effects , Stem Cells/cytology , Basic Helix-Loop-Helix Transcription Factors/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Humans , Nerve Tissue Proteins/metabolism , Neurons/drug effects , Neurons/metabolism , Protein Transport/drug effects , Receptor, TIE-2/metabolism , Repressor Proteins , Stem Cells/drug effects , Stem Cells/metabolism
18.
Dev Growth Differ ; 52(3): 293-301, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20298258

ABSTRACT

Gastrulation is the defining feature of metazoan development where it serves to apportion seemingly equivalent, pluripotent cells to specific fates. The three embryonic germ layers generated during gastrulation from the pluripotent epiblast including ectoderm, mesoderm, and definitive endoderm, contain the progenitors required to build all of the tissues of the developing organism. As a result, there is great interest in understanding the events that coordinate gastrulation. Because developing embryos in placental mammals are relatively inaccessible, stem cells are widely used for experimental and biochemical interrogation of these processes. Epiblast stem cells (EpiSCs) are grown from the post-implantation epiblast, which is the most proximal pluripotent tissue to the early somatic and germ cell precursors. Because EpiSCs can be propagated indefinitely in vitro as a stable state that recapitulates the properties of the post-implantation epiblast, they are uniquely positioned to provide novel insight into the developmental window where somatic and germ cell lineages are first established. Here we discuss the nature of EpiSCs and their significance in understanding gastrulation and cell specification in relationship to other pluripotent cell culture models.


Subject(s)
Embryonic Stem Cells/cytology , Germ Layers/cytology , Animals , Cell Differentiation , Cell Separation , Embryonic Stem Cells/metabolism , Epigenesis, Genetic , Female , Gastrulation/genetics , Gastrulation/physiology , Gene Expression Regulation, Developmental , Germ Layers/metabolism , Humans , Mice , Models, Biological , Nodal Protein/genetics , Nodal Protein/metabolism , Octamer Transcription Factor-3/genetics , Octamer Transcription Factor-3/metabolism , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/metabolism , Pregnancy , Primates , Signal Transduction
19.
PLoS One ; 5(2): e9414, 2010 Feb 26.
Article in English | MEDLINE | ID: mdl-20195471

ABSTRACT

BACKGROUND: The ability to grow a uniform cell type from the adult central nervous system (CNS) is valuable for developing cell therapies and new strategies for drug discovery. The adult mammalian brain is a source of neural stem cells (NSC) found in both neurogenic and non-neurogenic zones but difficulties in culturing these hinders their use as research tools. METHODOLOGY/PRINCIPAL FINDINGS: Here we show that NSCs can be efficiently grown in adherent cell cultures when angiogenic signals are included in the medium. These signals include both anti-angiogenic factors (the soluble form of the Notch receptor ligand, Dll4) and pro-angiogenic factors (the Tie-2 receptor ligand, Angiopoietin 2). These treatments support the self renewal state of cultured NSCs and expression of the transcription factor Hes3, which also identifies the cancer stem cell population in human tumors. In an organotypic slice model, angiogenic factors maintain vascular structure and increase the density of dopamine neuron processes. CONCLUSIONS/SIGNIFICANCE: We demonstrate new properties of adult NSCs and a method to generate efficient adult NSC cultures from various central nervous system areas. These findings will help establish cellular models relevant to cancer and regeneration.


Subject(s)
Angiogenesis Inducing Agents/pharmacology , Cell Proliferation/drug effects , Neurons/cytology , Stem Cells/cytology , Adult , Adult Stem Cells/cytology , Angiopoietin-2/pharmacology , Animals , Brain/cytology , Cell Culture Techniques , Cell Differentiation/drug effects , Cells, Cultured , DNA-Binding Proteins/metabolism , Fibroblast Growth Factors/pharmacology , Haplorhini , Humans , Immunohistochemistry , Intracellular Signaling Peptides and Proteins , Membrane Proteins/pharmacology , Mice , Rats , Repressor Proteins , Transcription Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...